TY - CONF
TI - Daratumumab with Dexamethasone in Patients with Relapsed/Refractory Multiple Myeloma and Severe Renal Impairment: Results on Efficacy and Safety of the Phase 2 Dare Study
AU - Kastritis, Efstathios
AU - Terpos, Evangelos
AU - Symeonidis, Argiris
AU - Delimpasi, Sosana
AU - Cavo, Michele
AU - Zamagni, Elena
AU - Katodritou, Eirini
AU - Rivolti, Elena
AU - Kyrtsonis, Marie-Christine
AU - Gavriatopoulou, Maria
AU - others
PY - 2020
SP - null
PB - 
T2 - BLOOD
TODO - null
TODO - null
TODO - null
ER -